AFMD: Affimed N.V. Company Profile & Statistics

About

Affimed N.V is a clinical stage biopharmaceutical company. It is engaged in developing single and combination therapies to treat cancers. The company's product pipeline consists of AFM13, AFM24, AFM26, AFM11 and AMV564 which are in clinical stage. Affimed N.V, formerly known as Affimed Therapeutics B.V., is based in Heidelberg, Germany.

Info & Links

CEO

Andreas Harstrick

Headquarters

GOTTLIEB-DAIMLER-STRASSE 2
MANNHEIM, 2M 68165, GERMANY

Auditor

KPMG AG Wirtschaftspr¿fungsgesellschaft

Share holders

Employees

Affimed N.V. Statistics

Valuation Measures

Market Capitalization²

17.55M

Enterprise Value

18.27M

Enterprise Value/EBITDA(ttm)

-0.25

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

18.96

Price to Book(mrq)

0.97

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-7836.98%

Profit Margin(ttm)

-9215.77%

Return on Equity(ttm)

-193.84%

Return on Invested Capital(ttm)

-199.13%

Return on Assets(ttm)

-107.24%

Income Statement

Revenue(ttm)

968.40K

Revenue Per Share(ttm)

Gross Profit(ttm)

968.40K

EBITDA(ttm)³

-72.36M

Net Income Available to Common(ttm)

-75.87M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

2.17

52-Week Change

-76.01%

S&P 500 52-Week Change

25.26%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

15.49M

% Held by Insiders

3.80%

% Held by Institutions

30.82%

Balance Sheet

Total Cash(mrq)

27.42M

Total Cash Per Share(mrq)

Total Debt(mrq)

8.87M

Total Debt/Equity(mrq)

46.90%

Current Ratio(mrq)

1.93%

Quick Ratio(mrq)

1.93%

Book Value Per Share(mrq)

1.15

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.51

Free Cash Flow(ytd)

-55.77M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

AFMD

Affimed N.V.

Affimed N.V. Profile